Europe Airlines Face Traveler Crash Fears Who Is New Porsche Boss Michael Macht? Intel Appeals EU Antitrust Ruling BP: Iraq Oil Deal is Start of Something Big Europe Issues New Bank Guidelines Story Tools post a comment e-mail this story print this story order a reprint suggest a story digg this save to del.icio.us linkedin connections British pharmaceutical giant GlaxoSmithKline (GSK) is set to reap billions as fear of the swine flu pandemic grows. The world’s second-largest drug company has secured orders from 16 countries for 195 million doses of the vaccine it is developing against the H1N1 virus, which has killed more than 740 people worldwide. Read more at globalresearch.ca |
